高竞争与低竞争医院市场中高风险手术的结局
该回顾性研究纳入2015至2018年接受10种高风险手术的2 242 438例65岁及以上Medicare受益人,按医院市场赫芬达尔-赫希曼指数分为高竞争与低竞争市场。结果显示,高竞争市场医院在2/10种手术的30天死亡率更高、5/10种手术的30天再入院率更高,其余无差异;医院市场竞争与高风险手术结局改善无一致关联。
要点
- 高竞争市场医院二尖瓣修复30天死亡率更高(OR 1.11,95%CI 1.07-1.14)。
- 高竞争市场医院颈动脉内膜切除术30天死亡率更高(OR 1.06,95%CI 1.03-1.09)。
- 高竞争市场医院5/10种手术30天再入院率更高,幅度从OR 1.01至OR 1.05。
核心结论
- 医院市场竞争与高风险手术结局改善无一致关联,维持医院市场竞争的努力可能不会带来更好的术后结局。
研究设计与样本
- 回顾性研究,纳入2015至2018年在美国医院接受10种高风险手术之一择期手术的65岁及以上Medicare受益人,共2 242 438例。
- 根据医院市场赫芬达尔-赫希曼指数将医院分为高竞争市场和低竞争市场。
- 采用多变量逻辑回归模型对30天死亡率和30天再入院率进行风险调整,调整患者因素(年龄、性别、合并症、双重资格)、手术年份和医院特征(护士比和教学状态)。
- 数据分析时间为2022年5月至2023年3月。
主要发现
- 队列平均(SD)年龄74.1(6.4)岁,女性1 328 946例(59.3%),男性913 492例(40.7%)。
- 与低竞争医院相比,高竞争市场医院在2/10种手术中30天死亡率更高:二尖瓣修复OR 1.11(95%CI 1.07-1.14),颈动脉内膜切除术OR 1.06(95%CI 1.03-1.09)。
- 高竞争市场医院在5/10种手术中30天再入院率更高:开放腹主动脉瘤修复、膝关节置换、二尖瓣修复、直肠切除和颈动脉内膜切除术,范围从膝关节置换OR 1.01(95%CI 1.00-1.02)至直肠切除OR 1.05(95%CI 1.02-1.08)。
- 高竞争市场医院在5/10种手术中30天死亡率无差异:开放腹主动脉瘤修复、减重手术、食管切除术、膝关节置换和髋关节置换,范围从髋关节置换OR 0.97(95%CI 0.94-1.00)至减重手术OR 1.09(95%CI 0.94-1.26)。
- 高竞争市场医院在3种手术中30天再入院率无差异:减重手术OR 1.03(95%CI 0.99-1.07)、食管切除术OR 1.02(95%CI 0.99-1.06)、胰腺切除术OR 1.00(95%CI 0.99-1.01)。
关键数值与推荐
- 高竞争市场医院二尖瓣修复30天死亡率OR 1.11(95%CI 1.07-1.14)。
- 高竞争市场医院颈动脉内膜切除术30天死亡率OR 1.06(95%CI 1.03-1.09)。
- 高竞争市场医院直肠切除30天再入院率OR 1.05(95%CI 1.02-1.08)。
- 高竞争市场医院膝关节置换30天再入院率OR 1.01(95%CI 1.00-1.02)。
- 高竞争市场医院髋关节置换30天死亡率OR 0.97(95%CI 0.94-1.00)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Maintaining competition among hospitals is increasingly seen as important to achieving high-quality outcomes. Whether or not there is an association between hospital market competition and outcomes after high-risk surgery is unknown. OBJECTIVE: To evaluate whether there is an association between hospital market competition and outcomes after high-risk surgery. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective study of Medicare beneficiaries who received care in US hospitals. Participants were 65 years and older who electively underwent 1 of 10 high-risk surgical procedures from 2015 to 2018: carotid endarterectomy, mitral valve repair, open aortic aneurysm repair, lung resection, esophagectomy, pancreatectomy, rectal resection, hip replacement, knee replacement, and bariatric surgery. Hospitals were categorized into high-competition and low-competition markets based on the hospital market Herfindahl-Hirschman index. Comparisons of 30-day mortality and 30-day readmissions were risk-adjusted using a multivariate logistic regression model adjusting for patient factors (age, sex, comorbidities, and dual eligibility), year of procedure, and hospital characteristics (nurse ratio and teaching status). Data were analyzed from May 2022 to March 2023. MAIN OUTCOMES AND MEASURES: Thirty-day postoperative mortality and readmissions. RESULTS: A total of 2 242 438 Medicare beneficiaries were included in the study. The mean (SD) age of the cohort was 74.1 (6.4) years, 1 328 946 were women (59.3%), and 913 492 were men (40.7%). When examined by procedure, compared with low-competition hospitals, high-competition market hospitals demonstrated higher 30-day mortality for 2 of 10 procedures (mitral valve repair: odds ratio [OR], 1.11; 95% CI, 1.07-1.14; and carotid endarterectomy: OR, 1.06; 95% CI, 1.03-1.09) and no difference for 5 of 10 procedures (open aortic aneurysm repair, bariatric surgery, esophagectomy, knee replacement, and hip replacement; ranging from OR, 0.97; 95% CI, 0.94-1.00, for hip replacement to OR, 1.09; 95% CI, 0.94-1.26, for bariatric surgery). High-competition hospitals also demonstrated 30-day readmissions that were higher for 5 of 10 procedures (open aortic aneurysm repair, knee replacement, mitral valve repair, rectal resection, and carotid endarterectomy; ranging from OR, 1.01; 95% CI, 1.00-1.02, for knee replacement to OR, 1.05; 95% CI, 1.02-1.08, for rectal resection) and no difference for 3 procedures (bariatric surgery: OR, 1.03; 95% CI, 0.99-1.07; esophagectomy: OR, 1.02; 95% CI, 0.99-1.06; and pancreatectomy: OR, 1.00; 95% CI, 0.99-1.01). Hospitals in high-competition compared with low-competition markets cared for patients who were older (mean [SD] age of 74.4 [6.6] years vs 74.0 [6.2] years, respectively; P < .001), were more likely to be racial and ethnic minority individuals (77 322/450 404 [17.3%] vs 23 328/444 900 [5.6%], respectively; P < .001), and had more comorbidities (≥2 Elixhauser comorbidities, 302 415/450 404 [67.1%] vs 284 355/444 900 [63.9%], respectively; P < .001). CONCLUSIONS AND RELEVANCE: This study found that hospital market competition was not consistently associated with improved outcomes after high-risk surgery. Efforts to maintain hospital market competition may not achieve better postoperative outcomes.
引用
- Thumma SR, Dualeh SHA, Kunnath NJ, et al. Outcomes for High-Risk Surgical Procedures Across High- and Low-Competition Hospital Markets. JAMA Surg. 2023. PMID: 37531126. doi:10.1001/jamasurg.2023.3221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。